Suppression of Erythroid but Not Megakaryocytic Differentiation of Human K562 Erythroleukemic Cells by Notch-1
0301 basic medicine
Erythrocytes
Dose-Response Relationship, Drug
Benzidines
Blotting, Western
Calcium-Binding Proteins
Down-Regulation
Cell Differentiation
Ligands
DNA, Antisense
DNA-Binding Proteins
03 medical and health sciences
Basic Helix-Loop-Helix Transcription Factors
Erythroid-Specific DNA-Binding Factors
Hemin
Humans
Intercellular Signaling Peptides and Proteins
GATA1 Transcription Factor
Leukemia, Erythroblastic, Acute
K562 Cells
Megakaryocytes
Jagged-1 Protein
DOI:
10.1074/jbc.m002866200
Publication Date:
2002-07-26T14:56:47Z
AUTHORS (5)
ABSTRACT
The Notch signal transduction pathway is a highly conserved regulatory system that controls multiple developmental processes. We have established an erythroleukemia cell model to study how Notch regulates cell fate and erythroleukemic cell differentiation. K562 and HEL cells expressed the Notch-1 receptor and the Notch ligand Jagged-1. The stable expression of the constitutively active intracellular domain of Notch-1 (NIC-1) in K562 cells inhibited erythroid without affecting megakaryocytic maturation. Expression of antisense Notch-1 induced spontaneous erythroid maturation. Suppression of erythroid maturation by NIC-1 did not result from down-regulation of GATA-1 and TAL-1, transcription factors necessary for erythroid differentiation. Microarray gene expression analysis identified genes activated during erythroid maturation, and NIC-1 disrupted the maturation-dependent changes in the expression of these genes. These results show that NIC-1 alters the pattern of gene expression in K562 cells leading to a block in erythroid maturation and therefore suggest that Notch signaling may control the developmental potential of normal and malignant erythroid progenitor cells.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (67)
CITATIONS (75)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....